Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study

被引：0
作者：
Jiaxi Zhao
Rong Chen
Mengqi Luo
Hongping Gong
Kaixin Li
Qian Zhao
机构：
[1] Sichuan University,General Practice Ward/International Medical Center Ward General Practice Medical Center, West China Hospital
[2] Sun Yat-Sen University,Department of Rehabilitation Medicine, The First Affiliated Hospital
[3] Sichuan University,Department of Gastroenterology and Hepatology, West China Hospital
[4] Huadong Hospital,Department of Nephrology
来源：
Diabetology & Metabolic Syndrome | / 16卷
关键词：
Inflammatory bowel disease; Lipid- lowering drug; Mendelian randomization; Crohn’s disease; Ulcerative colitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
What is already known? IBD were associated with lipid-lowering drugs in previous studies, but the causal relationship is unknown. There were two studies exploring the relationship, but the results were inconsistant.
引用
收藏
相关论文
共 130 条
[61]  
Ference BA(undefined)undefined undefined undefined undefined-undefined
[62]  
Huang W(undefined)undefined undefined undefined undefined-undefined
[63]  
Xiao J(undefined)undefined undefined undefined undefined-undefined
[64]  
Ji J(undefined)undefined undefined undefined undefined-undefined
[65]  
Chen L(undefined)undefined undefined undefined undefined-undefined
[66]  
Li Z(undefined)undefined undefined undefined undefined-undefined
[67]  
Zhang B(undefined)undefined undefined undefined undefined-undefined
[68]  
Liu Q(undefined)undefined undefined undefined undefined-undefined
[69]  
Williams DM(undefined)undefined undefined undefined undefined-undefined
[70]  
Finan C(undefined)undefined undefined undefined undefined-undefined
234567891011